M A Espinal
Affiliation: World Health Organization
- Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance SurveillanceM A Espinal
Communicable Diseases Cluster, World Health Organization, Geneva, Switzerland
N Engl J Med 344:1294-303. 2001..Data on global trends in resistance to antituberculosis drugs are lacking...
- Drug-resistant tuberculosis in the Dominican Republic: results of a nationwide surveyM A Espinal
National Research Center for Maternal and Child Health CENISMI, Santo Domingo, Dominican Republic
Int J Tuberc Lung Dis 2:490-8. 1998..The Dominican Republic...
- Infectiousness of Mycobacterium tuberculosis in HIV-1-infected patients with tuberculosis: a prospective studyM A Espinal
National Centre for Research on Maternal and Child Health, Santo Domingo, Dominican Republic
Lancet 355:275-80. 2000..Thus, we assessed the effect of HIV-1 on the infectiousness of Mycobacterium tuberculosis in a prospective study...
- Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countriesM A Espinal
World Health Organization, Communicable Diseases Programme, Ave Appia 20, 1211 Geneva 27, Switzerland
JAMA 283:2537-45. 2000....
- Determinants of drug-resistant tuberculosis: analysis of 11 countriesM A Espinal
World Health Organization, Communicable Diseases, Geneva, Switzerland
Int J Tuberc Lung Dis 5:887-93. 2001..Eleven countries/territories...
- Will tuberculosis become resistant to all antibiotics?C Dye
Communicable Diseases, World Health Organization, Geneva, Switzerland
Proc Biol Sci 268:45-52. 2001..To substantiate this result, further measurements are needed of the relative fitness of drug-resistant strains...
- The burden of drug-resistant tuberculosis and mechanisms for its controlM C Raviglione
Communicable Diseases, Stop TB, World Health Organization, Geneva, Switzerland
Ann N Y Acad Sci 953:88-97. 2001..The global epidemiology of drug-resistant TB, the impact of standardized short-course chemotherapy (SSC), and the potential future evolution of MDR TB are discussed in this chapter...
- Adverse events in the treatment of multidrug-resistant tuberculosis: results from the DOTS-Plus initiativeE Nathanson
Stop TB Department, World Health Organization, Geneva, Switzerland
Int J Tuberc Lung Dis 8:1382-4. 2004..The study shows that adverse events are manageable in the treatment of MDR-TB in resource-limited settings provided that standard management strategies are applied...